Chennai-based R. Radha did not let rheumatoid arthritis (or negative comments) stop her from leading a full life as a wife, mother and grandmother. Here, she talks about the treatments, therapies and determination that helps her fight her condition.
My struggle with rheumatoid arthritis started when I was 22 years old. It was November 1956. Every day I used to wake up early in the morning to make coffee. But that morning, my entire body, especially the joints in my…
Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Changed
06/Sep/2014
Condition
